That has made the drugs blockbuster treatments for type 2 diabetes and obesity
Para el manejo del peso, estn indicados en adultos con ndice de masa corporal (IMC) 30 kg/m o 27 kg/m con al menos una comorbilidad relacionada con el peso (hipertensin, dislipidemia, diabetes tipo 2)
Patients with cardiovascular (CV) risk, for instance, FDCs planned with sitagliptin and metformin or empagliflozin have shown superiority versus monotherapy on the grounds of treatment efficacy in clinical trials [29]
More common side effects include nausea/vomiting and pancreatitis
Mitochondrial dysfunction is considered one of the early pathogenic factors of cognitive impairment in the developing or aging brain after general anesthesia [22, 56], and it is also a significant feature of aging and neuronal degeneration [22, 23]
and significant improvements in ALT, AST, bilirubin, bile acids, cytokeratin-18, insulin, estimated glomerular filtration rate, ELF score, and hepatic stiffness by transient elastography (p 0.05 in all cases)
-(1).png?sfvrsn=c236e848_3)
